Dde-D-Dab(Fmoc)-OH

Dde-D-Dab(Fmoc)-OH is a chiral, protected amino acid derivative built on the Dab (2,4-diaminobutyric) side-chain architecture, bearing an N-Fmoc group for base-labile peptide coupling compatibility and a Dde (1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) protecting group on the side-chain amino functionality to enable orthogonal deprotection. The molecule contains a carboxylic acid (OH) for C-terminal activation and amide bond formation, while its two stereogenic elements associated with the D-configuration and the protected side-chain arrangement provide stereochemical control during peptide assembly. The Dde group is designed for selective removal under mild hydrazine-based conditions, whereas the Fmoc group is removed under basic conditions, creating a practical orthogonal protection strategy for iterative synthesis. The resulting reactivity profile supports standard peptide coupling chemistry at the α-carboxylate and enables downstream transformations that preserve the Dab side-chain for further functionalization or conjugation.

1. Orthogonal Peptide Synthesis

Dde-D-Dab(Fmoc)-OH is applied in orthogonally protected peptide synthesis where sequential N- and side-chain deprotection is required to control which amine participates in coupling at each step. The Fmoc group on the α-amino position supports routine base-mediated deprotection to expose the primary amine for peptide bond formation, while the Dde-protected side-chain amine remains masked to prevent undesired branching or crosslinking. The free carboxylic acid enables activation and coupling as a protected amino acid building block, allowing incorporation of D-Dab residues into peptide backbones with defined stereochemistry. The protected Dab side-chain can then be revealed at chosen stages to generate side-chain-specific amide formation, branching, or conjugation handles, supporting robust construction of complex peptide architectures. The orthogonal protection pattern makes the compound suitable for iterative solid-phase or solution-phase peptide assembly workflows that require controlled chemoselectivity.

2. Peptidomimetic Construction

Dde-D-Dab(Fmoc)-OH is utilized in peptidomimetic and constrained scaffold design where the Dab side chain contributes a spatially defined amine for receptor-facing interactions or intramolecular constraint strategies. The D-configuration and the protected side-chain amine enable incorporation of stereochemically defined amino acid units that can influence conformational preferences in peptide analogs. The Fmoc-protected α-amino group supports incorporation into longer sequences, while the Dde group allows selective side-chain unveiling to install functional groups such as amide substituents, urea/guanidine-like motifs, or linker moieties for downstream derivatization. The resulting analogs can be prepared as structure-defined intermediates for medicinal chemistry programs that rely on systematic variation of side-chain chemistry. The compound's orthogonal protection and chiral amino acid framework align with amino acid derivatization and peptidomimetic construction strategies in synthetic organic chemistry.

3. Chemical Biology Labeling

Dde-D-Dab(Fmoc)-OH is suitable for chemical biology workflows that require site-selective introduction of amine-bearing functionalities into peptides or peptide-derived probes. The masked side-chain amine under Dde protection can be revealed on demand, enabling controlled conjugation to activated electrophiles such as activated carboxylic acids, NHS-esters, aldehydes, or other amine-reactive labeling reagents. The Fmoc group supports orderly peptide assembly to position the Dab residue within a defined sequence context, improving control over labeling site placement. The carboxylic acid functionality allows incorporation at specific positions as part of a probe precursor, after which the deprotected side-chain can be used to attach fluorophores, affinity tags, or crosslinkers. The stereochemical integrity of the D-Dab unit helps maintain consistent structural features across probe libraries used in biochemical research.

4. SAR Studies Intermediates

Dde-D-Dab(Fmoc)-OH serves as a chiral intermediate for structure-activity relationship studies where systematic modification of Dab side-chain chemistry is needed while keeping the peptide backbone constant. The orthogonally protected side-chain amine enables late-stage diversification: Dde deprotection can be timed to generate a reactive amine for coupling to diverse substituents without disturbing earlier peptide segments. The Fmoc-protected α-amino group supports consistent peptide coupling conditions, reducing variability introduced by protecting-group changes across analog series. The D-configuration provides a defined stereochemical handle that can be maintained across analog synthesis, supporting reproducible comparisons in SAR-focused chemical libraries. The compound thereby functions as a practical amino acid derivatization platform for generating peptide analogs and downstream derivatives used in medicinal chemistry and biochemical screening campaigns.

5. Pharmaceutical Manufacturing Intermediate

Dde-D-Dab(Fmoc)-OH is applicable to pharmaceutical manufacturing and fine chemical production of protected peptide building blocks where orthogonal protection strategies improve process control during intermediate preparation. The Fmoc group enables standardized deprotection under controlled basic conditions, while the Dde group allows selective side-chain unmasking without requiring harsh conditions that would compromise other functional groups. The presence of a free carboxylic acid supports incorporation into peptide intermediates through conventional activation and coupling steps, aligning with scalable peptide synthesis practices. The chiral D-Dab residue and protected amine pattern support consistent formation of defined peptide intermediates used in downstream synthesis of peptide-based active ingredients or key intermediates. The compound's protection-group logic and functional group compatibility make it suitable for process chemistry intermediate preparation where chemoselectivity and reproducibility are essential for manufacturing workflows.

1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation